Author

A. M. A. Ferrer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Organism:human· 1

Frequent Co-Authors

C. C. Deocaris· 2 shared J. R. A. David· 2 shared M. V. Alinsug· 2 shared A. A. Bautista· 1 shared A. A. Tanquiqui· 1 shared A. A. Taquiqui· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

C. C. Deocaris

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacological mechanisms on the anti-breast cancer property of Coix lacryma-jobi: A network-based analysis

A. M. A. Ferrer, J. R. A. David, A. A. Taquiqui, A. A. Bautista, C. C. Deocaris, M. V. Alinsug

This study identifies the pharmacological mechanisms of Coix lacryma-jobi's anti-breast cancer effects through network pathway analysis of bioactive compounds and target genes.

bioRxiv · Oct 16, 2021 · PreprintPharmacology & Toxicology

Network-based analysis on the pharmacological mechanisms underlying the anti-diabetic property of Coix lachryma-jobi

A. A. Tanquiqui, A. M. A. Ferrer, J. R. A. David, C. C. Deocaris, M. V. Alinsug

This study identifies bioactive compounds and targets of Coix lachryma-jobi using network analysis to elucidate its anti-diabetic mechanisms.

bioRxiv · Oct 15, 2021 · PreprintPharmacology & Toxicology